GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fuji Pharma Co Ltd (TSE:4554) » Definitions » Cyclically Adjusted PS Ratio

Fuji Pharma Co (TSE:4554) Cyclically Adjusted PS Ratio : (As of Jun. 02, 2025)


View and export this data going back to 2011. Start your Free Trial

What is Fuji Pharma Co Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Fuji Pharma Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Fuji Pharma Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fuji Pharma Co Cyclically Adjusted PS Ratio Chart

Fuji Pharma Co Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.18 1.06 0.86 0.89 0.90

Fuji Pharma Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.23 1.08 0.90 1.09 -

Competitive Comparison of Fuji Pharma Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Fuji Pharma Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fuji Pharma Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fuji Pharma Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Fuji Pharma Co's Cyclically Adjusted PS Ratio falls into.


;
;

Fuji Pharma Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Fuji Pharma Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Fuji Pharma Co's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0/111.1000*111.1000
=0.000

Current CPI (Mar. 2025) = 111.1000.

Fuji Pharma Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 241.249 98.400 272.386
201509 290.262 98.500 327.392
201512 298.482 98.100 338.036
201603 264.374 97.900 300.020
201606 273.815 98.100 310.100
201609 307.510 98.000 348.616
201612 298.529 98.400 337.059
201703 280.406 98.100 317.565
201706 290.411 98.500 327.560
201709 313.087 98.800 352.064
201712 332.654 99.400 371.809
201803 267.335 99.200 299.404
201806 331.150 99.200 370.875
201809 335.439 99.900 373.046
201812 343.504 99.700 382.781
201903 274.088 99.700 305.428
201906 284.295 99.800 316.485
201909 287.378 100.100 318.958
201912 287.870 100.500 318.232
202003 254.726 100.300 282.154
202006 256.580 99.900 285.346
202009 285.412 99.900 317.410
202012 298.309 99.300 333.758
202103 287.526 99.900 319.761
202106 338.174 99.500 377.599
202109 349.652 100.100 388.075
202112 389.077 100.100 431.833
202203 340.685 101.100 374.383
202206 359.924 101.800 392.805
202209 368.605 103.100 397.207
202212 411.443 104.100 439.110
202303 379.747 104.400 404.118
202306 422.064 105.200 445.735
202309 469.327 106.200 490.981
202312 442.131 106.800 459.932
202403 437.726 107.200 453.651
202406 484.059 108.200 497.033
202409 534.038 108.900 544.827
202412 534.561 110.700 536.493
202503 0.000 111.100 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Fuji Pharma Co  (TSE:4554) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Fuji Pharma Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Fuji Pharma Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Fuji Pharma Co Business Description

Traded in Other Exchanges
N/A
Address
5-7 Sanban-cho, Chiyoda-ku, Tokyo, JPN, 102-0075
Fuji Pharma Co Ltd is the development, manufacture, and marketing of pharmaceutical products, such as injection agents, internal drugs, drugs for external use, and diagnostic products.

Fuji Pharma Co Headlines

No Headlines